The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.
The recombined cccDNA produced using minicircle technology mimicked HBV genome in structure and function closely.
复制标题
利用小环技术产生的重组cccDNA在结构和功能上与HBV基因组非常相似
DOI:
10.1038/srep25552
复制
发表时间:
2016-05-13
影响因子:
4.6
通讯作者:
Chen ZY
中科院分区:
文献类型:
--
作者:
Guo X;Chen P;Hou X;Xu W;Wang D;Wang TY;Zhang L;Zheng G;Gao ZL;He CY;Zhou B;Chen ZY
HBV covalently closed circular DNA (cccDNA) is drug-resistant and responsible for viral persistence. To facilitate the development of anti-cccDNA drugs, we developed a minicircle DNA vector (MC)-based technology to produce large quantity of recombined cccDNA (rcccDNA) resembling closely to its wild-type counterpart both in structure and function. The rcccDNA differed to the wild-type cccDNA (wtcccDNA) only in that it carried an extra 36-bp DNA recombinant productattRupstream of the preC/C gene. Using a procedure similar to standard plasmid production, milligrams of rcccDNA can be generated in common laboratories conveniently. The rcccDNA demonstrated many essential biological features of wtcccDNA, including: (1) undergoing nucleation upon nucleus entry; (2) serving as template for production of all HBV RNAs and proteins; (3) deriving virions capable of infecting tree shrew, and subsequently producing viral mRNAs, proteins, rcccDNA and infectious virions. As an example to develop anti-cccDNA drugs, we used the Crispr/Cas9 system to provide clear-cut evidence that rcccDNA was cleaved by this DNA editing toolin vitro.In summary, we have developed a convenient technology to produce large quantity of rcccDNA as a surrogate of wtcccDNA for investigating HBV biology and developing treatment to eradicate this most wide-spreading virus.